サンプルお申込み

お問い合わせ

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は腎臓（腎）線維症市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは腎臓（腎）線維症の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の腎臓（腎）線維症市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは腎臓（腎）線維症のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に腎臓（腎）線維症市場を分類しています。本研究に含まれる主な企業は：Merck、Pfizer、Roche、InterMune、Galectin Therapeutics、La Jolla Pharmaceutical Company、ProMetic Life-Sciences Inc.、BioLine Rx Ltd、Genzyme Corporation

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Angiotensin Converting enzyme (ACE) Inhibitors
    Pirfenidone
    Renin Inhibitors
    Angiotensin II Receptor Blockers (ARBs)
    Vasopeptidase Inhibitors

用途別の市場セグメント：
    Research Center
    Hospital
    Clinic

本レポートの詳細内容
世界の腎臓（腎）線維症市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、腎臓（腎）線維症タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の腎臓（腎）線維症収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の腎臓（腎）線維症市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、腎臓（腎）線維症市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

腎臓（腎）線維症のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：腎臓（腎）線維症のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：腎臓（腎）線維症の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章腎臓（腎）線維症企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：腎臓（腎）線維症の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：腎臓（腎）線維症の主要企業の概要を提供し、製品の説明と仕様、腎臓（腎）線維症の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Kidney fibrosis is characterized by excessive production and deposition of extracellular matrix (ECM) proteins mainly in the kidney interstitium and results in structural damage, impairment of renal function, and eventually end-stage renal disease (ESRD).

Market Analysis and Insights: Global Kidney (Renal) Fibrosis Market
The global Kidney (Renal) Fibrosis market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Kidney (Renal) Fibrosis market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Kidney (Renal) Fibrosis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Kidney (Renal) Fibrosis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Kidney (Renal) Fibrosis revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Kidney (Renal) Fibrosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Kidney (Renal) Fibrosis revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Pfizer, Roche, InterMune, Galectin Therapeutics, La Jolla Pharmaceutical Company, ProMetic Life-Sciences Inc., BioLine Rx Ltd and Genzyme Corporation, etc.
Market Segmentation
By Company
    Merck
    Pfizer
    Roche
    InterMune
    Galectin Therapeutics
    La Jolla Pharmaceutical Company
    ProMetic Life-Sciences Inc.
    BioLine Rx Ltd
    Genzyme Corporation

Segment by Type
    Angiotensin Converting enzyme (ACE) Inhibitors
    Pirfenidone
    Renin Inhibitors
    Angiotensin II Receptor Blockers (ARBs)
    Vasopeptidase Inhibitors

Segment by Application
    Research Center
    Hospital
    Clinic

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Kidney (Renal) Fibrosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney (Renal) Fibrosis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Kidney (Renal) Fibrosis revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Kidney (Renal) Fibrosis Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Angiotensin Converting enzyme (ACE) Inhibitors
    Table 3. Key Players of Pirfenidone
    Table 4. Key Players of Renin Inhibitors
    Table 5. Key Players of Angiotensin II Receptor Blockers (ARBs)
    Table 6. Key Players of Vasopeptidase Inhibitors
    Table 7. Global Kidney (Renal) Fibrosis Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Kidney (Renal) Fibrosis Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Kidney (Renal) Fibrosis Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Kidney (Renal) Fibrosis Market Share by Region (2019-2024)
    Table 11. Global Kidney (Renal) Fibrosis Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Kidney (Renal) Fibrosis Market Share by Region (2025-2030)
    Table 13. Kidney (Renal) Fibrosis Market Trends
    Table 14. Kidney (Renal) Fibrosis Market Drivers
    Table 15. Kidney (Renal) Fibrosis Market Challenges
    Table 16. Kidney (Renal) Fibrosis Market Restraints
    Table 17. Global Kidney (Renal) Fibrosis Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Kidney (Renal) Fibrosis Revenue Share by Players (2019-2024)
    Table 19. Global Top Kidney (Renal) Fibrosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney (Renal) Fibrosis as of 2023)
    Table 20. Global Kidney (Renal) Fibrosis Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Kidney (Renal) Fibrosis Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Kidney (Renal) Fibrosis, Headquarters and Area Served
    Table 23. Global Key Players of Kidney (Renal) Fibrosis, Product and Application
    Table 24. Global Key Players of Kidney (Renal) Fibrosis, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Kidney (Renal) Fibrosis Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Kidney (Renal) Fibrosis Revenue Market Share by Type (2019-2024)
    Table 28. Global Kidney (Renal) Fibrosis Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Kidney (Renal) Fibrosis Revenue Market Share by Type (2025-2030)
    Table 30. Global Kidney (Renal) Fibrosis Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Kidney (Renal) Fibrosis Revenue Share by Application (2019-2024)
    Table 32. Global Kidney (Renal) Fibrosis Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Kidney (Renal) Fibrosis Revenue Share by Application (2025-2030)
    Table 34. North America Kidney (Renal) Fibrosis Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Kidney (Renal) Fibrosis Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Kidney (Renal) Fibrosis Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Kidney (Renal) Fibrosis Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Kidney (Renal) Fibrosis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Kidney (Renal) Fibrosis Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Kidney (Renal) Fibrosis Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Kidney (Renal) Fibrosis Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Kidney (Renal) Fibrosis Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Kidney (Renal) Fibrosis Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Kidney (Renal) Fibrosis Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Kidney (Renal) Fibrosis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Kidney (Renal) Fibrosis Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Kidney (Renal) Fibrosis Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Kidney (Renal) Fibrosis Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Kidney (Renal) Fibrosis Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Kidney (Renal) Fibrosis Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Kidney (Renal) Fibrosis Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Kidney (Renal) Fibrosis Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Kidney (Renal) Fibrosis Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Kidney (Renal) Fibrosis Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Kidney (Renal) Fibrosis Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Kidney (Renal) Fibrosis Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Kidney (Renal) Fibrosis Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Kidney (Renal) Fibrosis Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Kidney (Renal) Fibrosis Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Kidney (Renal) Fibrosis Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Kidney (Renal) Fibrosis Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Kidney (Renal) Fibrosis Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Kidney (Renal) Fibrosis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Kidney (Renal) Fibrosis Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Kidney (Renal) Fibrosis Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Merck Company Details
    Table 67. Merck Business Overview
    Table 68. Merck Kidney (Renal) Fibrosis Product
    Table 69. Merck Revenue in Kidney (Renal) Fibrosis Business (2019-2024) & (US$ Million)
    Table 70. Merck Recent Developments
    Table 71. Pfizer Company Details
    Table 72. Pfizer Business Overview
    Table 73. Pfizer Kidney (Renal) Fibrosis Product
    Table 74. Pfizer Revenue in Kidney (Renal) Fibrosis Business (2019-2024) & (US$ Million)
    Table 75. Pfizer Recent Developments
    Table 76. Roche Company Details
    Table 77. Roche Business Overview
    Table 78. Roche Kidney (Renal) Fibrosis Product
    Table 79. Roche Revenue in Kidney (Renal) Fibrosis Business (2019-2024) & (US$ Million)
    Table 80. Roche Recent Developments
    Table 81. InterMune Company Details
    Table 82. InterMune Business Overview
    Table 83. InterMune Kidney (Renal) Fibrosis Product
    Table 84. InterMune Revenue in Kidney (Renal) Fibrosis Business (2019-2024) & (US$ Million)
    Table 85. InterMune Recent Developments
    Table 86. Galectin Therapeutics Company Details
    Table 87. Galectin Therapeutics Business Overview
    Table 88. Galectin Therapeutics Kidney (Renal) Fibrosis Product
    Table 89. Galectin Therapeutics Revenue in Kidney (Renal) Fibrosis Business (2019-2024) & (US$ Million)
    Table 90. Galectin Therapeutics Recent Developments
    Table 91. La Jolla Pharmaceutical Company Company Details
    Table 92. La Jolla Pharmaceutical Company Business Overview
    Table 93. La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Product
    Table 94. La Jolla Pharmaceutical Company Revenue in Kidney (Renal) Fibrosis Business (2019-2024) & (US$ Million)
    Table 95. La Jolla Pharmaceutical Company Recent Developments
    Table 96. ProMetic Life-Sciences Inc. Company Details
    Table 97. ProMetic Life-Sciences Inc. Business Overview
    Table 98. ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Product
    Table 99. ProMetic Life-Sciences Inc. Revenue in Kidney (Renal) Fibrosis Business (2019-2024) & (US$ Million)
    Table 100. ProMetic Life-Sciences Inc. Recent Developments
    Table 101. BioLine Rx Ltd Company Details
    Table 102. BioLine Rx Ltd Business Overview
    Table 103. BioLine Rx Ltd Kidney (Renal) Fibrosis Product
    Table 104. BioLine Rx Ltd Revenue in Kidney (Renal) Fibrosis Business (2019-2024) & (US$ Million)
    Table 105. BioLine Rx Ltd Recent Developments
    Table 106. Genzyme Corporation Company Details
    Table 107. Genzyme Corporation Business Overview
    Table 108. Genzyme Corporation Kidney (Renal) Fibrosis Product
    Table 109. Genzyme Corporation Revenue in Kidney (Renal) Fibrosis Business (2019-2024) & (US$ Million)
    Table 110. Genzyme Corporation Recent Developments
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Kidney (Renal) Fibrosis Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Kidney (Renal) Fibrosis Market Share by Type: 2023 VS 2030
    Figure 3. Angiotensin Converting enzyme (ACE) Inhibitors Features
    Figure 4. Pirfenidone Features
    Figure 5. Renin Inhibitors Features
    Figure 6. Angiotensin II Receptor Blockers (ARBs) Features
    Figure 7. Vasopeptidase Inhibitors Features
    Figure 8. Global Kidney (Renal) Fibrosis Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Kidney (Renal) Fibrosis Market Share by Application: 2023 VS 2030
    Figure 10. Research Center Case Studies
    Figure 11. Hospital Case Studies
    Figure 12. Clinic Case Studies
    Figure 13. Kidney (Renal) Fibrosis Report Years Considered
    Figure 14. Global Kidney (Renal) Fibrosis Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Kidney (Renal) Fibrosis Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Kidney (Renal) Fibrosis Market Share by Region: 2023 VS 2030
    Figure 17. Global Kidney (Renal) Fibrosis Market Share by Players in 2023
    Figure 18. Global Top Kidney (Renal) Fibrosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney (Renal) Fibrosis as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Kidney (Renal) Fibrosis Revenue in 2023
    Figure 20. North America Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Kidney (Renal) Fibrosis Market Share by Type (2019-2030)
    Figure 22. North America Kidney (Renal) Fibrosis Market Share by Application (2019-2030)
    Figure 23. North America Kidney (Renal) Fibrosis Market Share by Country (2019-2030)
    Figure 24. United States Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Kidney (Renal) Fibrosis Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Kidney (Renal) Fibrosis Market Share by Type (2019-2030)
    Figure 28. Europe Kidney (Renal) Fibrosis Market Share by Application (2019-2030)
    Figure 29. Europe Kidney (Renal) Fibrosis Market Share by Country (2019-2030)
    Figure 30. Germany Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Kidney (Renal) Fibrosis Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Kidney (Renal) Fibrosis Market Share by Type (2019-2030)
    Figure 38. China Kidney (Renal) Fibrosis Market Share by Application (2019-2030)
    Figure 39. Asia Kidney (Renal) Fibrosis Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Kidney (Renal) Fibrosis Market Share by Type (2019-2030)
    Figure 41. Asia Kidney (Renal) Fibrosis Market Share by Application (2019-2030)
    Figure 42. Asia Kidney (Renal) Fibrosis Market Share by Region (2019-2030)
    Figure 43. Japan Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Kidney (Renal) Fibrosis Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Kidney (Renal) Fibrosis Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Kidney (Renal) Fibrosis Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Kidney (Renal) Fibrosis Market Share by Country (2019-2030)
    Figure 53. Brazil Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Kidney (Renal) Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Merck Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2019-2024)
    Figure 60. Pfizer Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2019-2024)
    Figure 61. Roche Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2019-2024)
    Figure 62. InterMune Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2019-2024)
    Figure 63. Galectin Therapeutics Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2019-2024)
    Figure 64. La Jolla Pharmaceutical Company Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2019-2024)
    Figure 65. ProMetic Life-Sciences Inc. Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2019-2024)
    Figure 66. BioLine Rx Ltd Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2019-2024)
    Figure 67. Genzyme Corporation Revenue Growth Rate in Kidney (Renal) Fibrosis Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed